The phenotypes associated with MTRFR mutations are referred to as combined oxidative phosphorylation deficiency‐7 (COXPD7) or autosomal recessive spastic paraplegia type 55 (SPG55); the former was used as the designation for this disease. This evidence concerns the gene MTRFR and Autosomal recessive spastic paraplegia type 55.